تحذيرات السلامة

تصفية

#	العنوان	التاريخ	نوع الخبر	رابط الخبر
72	SFDA Recommendations for Healthcare Professionals Regarding The Unapproved Use of Hydroxychloroquine and Chloroquine in Treatment of COVID-19	2020-04-24	Warning	تحميل
71	SFDA Advises Continued Use of Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs) in Patients with COVID-19	2020-04-14	Precautions	تحميل
70	SFDA’s Advice on the Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Patients with COVID-19	2020-03-31	Precautions	تحميل
77	Safety Signal of Baricitinib and the Potential Risk of Diverticulitis	2020-03-25	Signal	تحميل
69	Risk of potentially fatal respiratory depression with benzodiazepines and opioids	2020-03-22	Warning	تحميل
68	Concern on Potential Risk of Respiratory Depression Associated with Gabapentinoids (pregabalin and gabapentin) medications	2020-01-23	Warning	تحميل
67	Ceftriaxone: a reminder for the risk of hypersensitivity	2019-12-24	Warning	تحميل
66	Concerns on paracetamol overdose in children	2019-11-29	Warning	تحميل
65	Risk of neuropsychiatric reactions with the use of Montelukast	2019-10-11	Warning	تحميل
64	Risk of Myocarditis Associated With the Use of Atezolizumab	2018-10-23	Warning and Precaution	تحميل